End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.3 CNY | +1.37% | +4.60% | -2.06% |
07:16am | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
Apr. 17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Jiangsu Hengrui Medicine Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.18% | 2 M€ | -18.13% | - | |
3.73% | 2 M€ | -14.14% | ||
1.74% | 1 M€ | -9.86% | - | |
1.18% | 96 M€ | -3.91% | ||
0.51% | 35 M€ | -5.85% | - | |
0.27% | 4 M€ | -11.56% | ||
0.15% | 11 M€ | +0.55% | ||
0.07% | 1 M€ | +3.49% | - | |
0.07% | 3 M€ | -.--% | - | |
0.03% | 441 M€ | +3.02% | - | |
0.03% | 2,808 M€ | +5.90% | - | |
0.03% | 149 M€ | +0.92% | - | |
0.03% | 117 M€ | +0.16% | - | |
0.03% | 4 M€ | -4.41% | - | |
0.01% | 31 M€ | +3.34% | - | |
0.00% | 7 M€ | +1.87% | - | |
0.00% | 34 M€ | +2.22% | - | |
0.00% | 389 M€ | +6.39% | - | |
0.00% | 34 M€ | +4.85% | - | |
0.00% | 147 M€ | +4.88% | - | |
0.00% | 39 M€ | +2.96% | - | |
0.00% | 302 M€ | +3.91% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.06% | 38.88B | |
+23.86% | 653B | |
+25.77% | 556B | |
-6.55% | 354B | |
+20.74% | 331B | |
+5.54% | 296B | |
+12.66% | 233B | |
+5.30% | 201B | |
-9.98% | 193B | |
-6.46% | 144B |
- Stock Market
- Equities
- 600276 Stock
- Funds and ETFs Jiangsu Hengrui Medicine Co., Ltd.